Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Home Care Professionals
Home Care Professionals Home Care Professionals

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Home Care Conferences &
Educational Opportunities








Ongoing

Skin, Bones, Hearts & Private Parts - CME NOW OnDemand

Skin, Bones, Hearts & Private Parts

Dec. 3 - 07

Midyear Clinical Meeting and Exhibition

ASHP

More Events

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time | NEWS-Line for Occupational Therapists & COTAs

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time


Source:

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data. The findings, published today in Cell Reports Medicine, are from a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial was led by NIAID’s Infectious Diseases Clinical Research Consortium.

As part of a “mix and match” clinical trial, investigators administered COVID-19 booster vaccines to adults in the United States who had previously received a primary COVID-19 vaccination series under Emergency Use Authorization. Some participants received the same vaccine as their primary series, and others received a different vaccine. Investigators then evaluated immune responses over time. Results previously reported in the New England Journal of Medicine showed all combinations of primary and booster vaccines resulted in increased neutralizing antibody levels in the recipients.

In the new analysis, investigators report that nearly all vaccine combinations evaluated (see table) elicited high levels of neutralizing antibodies to the Omicron BA.1 sub-lineage. However, antibody levels against Omicron were low in the group that received Ad26.COV2.S as both a primary vaccine and boost. Moreover, immune responses to Omicron in all groups waned substantially, with neutralizing antibody levels decreasing 2.4- to 5.3-fold by three months post-boost. Omicron sub-lineages BA.2.12.1 and BA.4/BA.5 were 1.5 and 2.5 times less susceptible to neutralization, respectively, compared to the BA.1 sub-lineage, and 7.5 and 12.4 times less susceptible relative to the ancestral D614G strain. BA.5 currently is the dominant variant in the U.S.

Primary Vaccination Series Single Booster Vaccination
Two doses of mRNA-1273 administered 28 days apart

mRNA-1273 (100 microgram dose)

Two doses of mRNA-1273 administered 28 days apart
mRNA-1273 (50 microgram dose)

One dose of Ad26.COV2.S Ad26.COV2.S
Two doses of BNT162b2 administered 21 days apart BNT162b2
One dose of Ad26.COV2.S BNT162b2
Two doses of BNT162b2 administered 21 days apart Ad26.COV2.S
The table above shows the COVID-19 vaccine combinations from the “mix & match” study evaluated in this report.

The authors note that the findings are consistent with real-world reports showing waning protection against SARS-CoV-2 infection during the Omicron wave in people who received a primary vaccine series plus a booster shot. Additionally, the immune response to Omicron sub-lineages show reduced susceptibility to these rapidly emerging subvariants. The data could be used to inform decisions regarding future vaccine schedule recommendations, including the need for variant vaccine boosting.

NIAID grants supporting this research were UM1AI48372, UM1AI148373, UM1AI148450, UM1AI148452, UM1AI148573, UM1AI148574, UM1AI148575, UM1AI148576, UM1AI148684 and UM1AI148689. Contract 75N93019C00050 from the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs) also provided support.

Articles
KE Lyke et al. Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS CoV-2 Omicron Variant. Cell Reports Medicine DOI: 10.1016/j.xcrm.2022.100679 (2022).

RL Atmar et al. Homologous and heterologous COVID-19 booster vaccinations. The New England Journal of Medicine DOI: 10.1056/NEJMoa2116414 (2022).

Who
Dr. John H. Beigel, associate director for clinical research in NIAID’s Division of Microbiology and Infectious Diseases, is available to discuss the study.

Contact
To schedule interviews, please contact the NIAID News & Science Writing Branch, (301) 402-1663, [email protected]

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov

NIH…Turning Discovery Into Health®

Source: National Institutes of Health (NIH)

Image: National Institute of Allergy and Infectious Diseases (NIAID)

Pictured: Transmission electron micrograph of SARS-CoV-2 virus particles (gold) within endosomes of a heavily infected nasal Olfactory Epithelial Cell




Post not cached because it doesn't exist


Share This!


Home Care Jobs


Full or Part Time First Shift Charge Nurse, 6am to 2 pm

Laporte City Nursing & Rehab Center
La Porte City, Iowa

Registered Nurses

Regional West Health Services
Scottsbluff, Nebraska

Nursing Faculty Full-time, Unlimited Position

Anoka-Ramsey Community College (ARCC)
Cambridge and Coon Rapids, Minnesota

Full or Part Time First Shift Charge Nurse, 6am to 2 pm

Laporte City Nursing & Rehab Center
La Porte City, Iowa

LPN - CNA - RN

Penndel Mental Health Center
Penndel, Pennsylvania

Dean of Nursing and Allied Health Professions

Harford Community College
Bel Air, Maryland

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.